CDER Issues Guidance on Next Generation Sequencing Data for Antiviral Products

Drug GMP Report
A A
CDER released final guidance on submitting next generation nucleotide sequence (NGS) data to support resistance assessments for antiviral drugs.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00